Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Cancer deaths related to obesity have surged drastically in the United States over the past two decades. Data shows these deaths increased from 3.73 million to a staggering 13.52 million.
This alarming assessment comes from a study conducted by researchers at Jersey Shore University Medical Center along with Hackensack Meridian Health. The findings were discussed last month during the Endocrine Society’s annual meeting, ENDO 2025, held in San Francisco.
The research involved a comprehensive analysis of over 33,000 deaths attributed to obesity-associated cancers between 1999 and 2020. This utilized mortality data collected by the Centers for Disease Control and Prevention.
The analysis highlighted that certain groups, including older adults, females, and racial minorities, are more significantly impacted. Alarmingly, the Midwest region displayed the highest rates of obesity-related cancer deaths, while the Northeast reported the lowest rates.
Particularly, states like Vermont, Minnesota, and Oklahoma exhibited the highest rates of these deaths, whereas Utah, Alabama, and Virginia recorded the lowest.
According to the CDC, over 40% of Americans experience obesity, a condition that heightens the risk for various cancers and other chronic diseases. These include high blood pressure, high cholesterol, diabetes, heart disease, and kidney disease.
Studies indicate that obesity is linked to a higher risk of developing 13 specific types of cancer, which collectively account for 40% of all cancer diagnoses in the U.S. annually.
Dr. Mohamed Bakr, a co-author of the study and associate director at Jersey Shore University Medical Center’s Residency Program, confirmed a more than threefold increase in obesity-related cancer mortality in the United States. He noted that the most significant rise was observed between 2018 and 2020.
Bakr emphasized the need for focused public health strategies, such as enhanced screening and improved healthcare access, particularly in high-risk rural and underserved areas. These strategies are crucial given the urgent link between obesity and cancer.
Dr. Robert Den, a radiation oncologist and chief medical officer at Alpha Tau Medical, expressed concern about the growing rates of certain cancers, particularly colorectal, endometrial, pancreatic, and postmenopausal breast cancer. He remarked that these cancers are increasingly affecting not only older adults but also younger individuals, a trend not observed a generation ago.
Den characterized these types of cancer as more aggressive and challenging to treat, leading to increased healthcare costs. He underscored that the combination of rising obesity rates and the large population at risk points to a heavier burden on individuals and healthcare systems.
Promoting a healthy body weight through a balanced diet, regular physical activity, and reduced alcohol consumption can effectively lower cancer risks. Den advocates for broader public health initiatives that encompass better nutrition education and access to healthier food options.
Additionally, Den highlights the importance of leveraging new technologies and therapies that could transform how these diseases are managed. He firmly believes that preventing obesity translates directly to cancer prevention. Taking proactive measures now can significantly enhance health outcomes for the population at large.
Dr. Sue Decotiis, a medical weight-loss specialist based in New York City, pointed out the potential benefits of using obesity and diabetes medications, such as GLP-1 medications. These drugs have shown promise in reducing cancer risk, marking a significant advancement in medical treatment.
Decotiis explained that in obese individuals, inflammatory fat cells produce cytokines that disrupt the body’s normal immune functions, often leading to cancer. Early cancer screenings, coupled with weight loss strategies, should be emphasized as effective measures to lower cancer risk.
She advocates for actively addressing obesity and insulin resistance while improving the food supply rather than reacting only after cancer has developed. Decotiis advises, “Take the state of being overweight seriously. If lifestyle changes do not lead to weight loss, seek help from a certified weight-loss physician.”
As obesity continues to pose a public health crisis, both physicians and patients alike must consider obesity management not just as a personal health issue, but as a crucial factor in the fight against cancer.